Sutton Wealth Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Sutton Wealth Advisors’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-336	Closed	-$142	–	1176
2018 Q1	$142	Hold	336	–	–	﹤0.01%	1119
2017 Q4	$128	Hold	336	–	–	﹤0.01%	1074
2017 Q3	$121	Hold	336	–	–	﹤0.01%	1070
2017 Q2	$128	Hold	336	–	–	﹤0.01%	1077
2017 Q1	$151	Hold	336	–	–	﹤0.01%	1057
2016 Q4	$128	Hold	336	–	–	﹤0.01%	1052
2016 Q3	$91	Hold	336	–	–	﹤0.01%	1042
2016 Q2	$81	Hold	336	–	–	﹤0.01%	1020
2016 Q1	$38	Buy	+336	New	+$36	﹤0.01%	1012

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BCM

Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

NGA

New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

Sutton Wealth Advisors's GCVRZ Position: Q2 2018 in Review

Sutton Wealth Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q2 2018, closing a stake of 336 shares — an estimated $142 sold.

Sutton Wealth Advisors first reported a position in GCVRZ in Q1 2016 and held it in 9 quarters. The position peaked at $151 in Q1 2017. 106 funds tracked by Wall St. Rank hold GCVRZ as of Q2 2018.

Sutton Wealth Advisors reported no remaining Sanofi Contingent Value Rights position as of Q2 2018 after selling out during the quarter.
Sutton Wealth Advisors sold 336 Sanofi Contingent Value Rights shares in Q2 2018, an estimated $142.
Sutton Wealth Advisors first reported a position in Sanofi Contingent Value Rights in Q1 2016 and held it in 9 quarters.
Sutton Wealth Advisors's Sanofi Contingent Value Rights position peaked at $151 in Q1 2017.
106 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q2 2018.

Based on Sutton Wealth Advisors's 13F filing for Q2 2018, filed 6 Nov 2023.